SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Trading Down 1.2% – Here’s What Happened

SWEDISH ORPHAN/S (OTCMKTS:SWTUY)’s share price was down 1.2% during trading on Tuesday . The stock traded as low as $24.38 and last traded at $24.38. 200 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 1,665 shares. The stock had previously closed at $24.67.

SWEDISH ORPHAN/S Stock Down 1.2%

The firm has a market cap of $6.64 billion, a PE ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81. The business has a 50 day simple moving average of $24.38 and a two-hundred day simple moving average of $24.38.

SWEDISH ORPHAN/S Company Profile

Swedish Orphan Biovitrum AB, known as Sobi, is a Sweden-based specialty pharmaceutical company focused on developing, manufacturing and commercializing medicines for rare diseases. The company’s primary therapeutic areas include hematology, immunology and other conditions with significant unmet medical needs.

Sobi’s portfolio includes treatments for inherited and acquired blood disorders, immune-mediated diseases and related specialty-care conditions. Its products and development programs are distributed across international markets, with commercial activities spanning Europe, North America and selected regions in the Middle East, Asia and other global markets.

The company traces its roots to Swedish pharmaceutical operations established in the 1930s and adopted its current name after Swedish Orphan International combined with Biovitrum in 2010.